Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02328339
Other study ID # REF-BEV-1797
Secondary ID
Status Completed
Phase N/A
First received December 19, 2014
Last updated August 28, 2015
Start date January 2015
Est. completion date August 2015

Study information

Verified date August 2015
Source Unilever R&D
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.


Description:

Epidemiological studies indicate that regular consumption of black tea reduces the risk of cardiovascular diseases. Tea consumption can result in improvements in endothelial function of conduit arteries as measured by flow mediated dilation.

Less is known however about its effects in other vascular beds. The study will test the hypothesis that tea affects endothelial function in the muscle microcirculation. This will be done by assessment of forearm blood flow using venous occlusion plethysmography after consumption of black tea against or placebo in a randomised, full cross-over study in 20 healthy middle-aged to elderly subjects


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria:

- Males and post menopausal (> 1 years) females

- Aged = 45 and = 75 years

- Body mass index (BMI) of = 18.0 and = 35.0 kg/m2

- Judged to be in good health on the basis of medical history, physical examination and routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, highly sensitive C-reactive protein).

- Normal blood coagulation as assessed by routine lab tests

Exclusion Criteria:

- Strenuous exercise > 2 hours per week. Strenuous exercise is defined as exercise which induces sweating and causes sufficient breathlessness to limit conversation

- Current smoker or has stopped smoking less than 6 months before start of study

- Self reported alcohol intake of > 21 units/week)

- Established cardiovascular disease or clinically significant arrhythmia

- Diabetes mellitus

- Blood pressure > 160/100 mmHg

- Taking medication that might affect endothelial function (as judged by the PI)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Tea
Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents
Placebo
Placebo matched to tea with respect to taste and appearance

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Unilever R&D Radboud University

Outcome

Type Measure Description Time frame Safety issue
Primary Forearm blood flow response to acetylcholine Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo During acetylcholine infusion 120-140 min after first tea/placebo intake No
Secondary Forearm blood flow response to sodium nitropusside Does tea ingestion change mean forearm blood flow response to sodium nitropusside when compared to placebo During sodium nitropusside infusion 170-190 min after first tea/placebo intake No
Secondary Forearm blood flow response to L-NMMA Does tea ingestion change mean forearm blood flow response to L-NG-monomethyl Arginine (L-NMMA) when compared to placebo During L-NMMA infusion 220-240 min after first tea/placebo intake No
See also
  Status Clinical Trial Phase
Completed NCT03866343 - Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals N/A
Completed NCT01945970 - Effect of Black Tea on Vascular Function N/A
Completed NCT02065271 - Herbal Preparation and Glucose Homeostasis N/A
Completed NCT01495325 - Effect of Woodsmoke on Vascular Function N/A
Terminated NCT04239482 - Nutritional Supplementation and Insulin Sensitivity N/A
Completed NCT02273323 - Flow Mediated Dilation in Response to Black Tea N/A
Completed NCT04550026 - Cardiovascular Effects of Heated Tobacco Products (HTP) N/A
Completed NCT03849300 - Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease N/A
Terminated NCT04770155 - Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1 Early Phase 1
Active, not recruiting NCT01312168 - Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment N/A
Not yet recruiting NCT06440512 - The Effect of Chocolate on Vascular Function of Endurance Runners N/A
Not yet recruiting NCT06229873 - Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure N/A
Recruiting NCT05468255 - The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults N/A
Completed NCT01805063 - Effect of Fire Suppression and Emergency Duties on Vascular Function
Completed NCT04700241 - Nitrate and Brain Insulin-Sensitivity N/A
Completed NCT01575041 - The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function N/A
Completed NCT03324256 - Energy Drinks and Vascular Function N/A
Completed NCT04175457 - The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis N/A
Completed NCT01053026 - Evaluation of Effects of Exercise Training and ARB in DM Patients N/A
Completed NCT03625596 - Nutritional Supplements and Nitric Oxide Bioactivity N/A